(Henry Ford Health System) NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, and Henry Ford Health System, a non-profit organization, today announce that a newly-formed subsidiary of NTS has entered into multi-year Sponsored Research and License Agreements. The new company is named NeurExo Sciences, LLC (NXS) and its goal is to advance Henry Ford's pioneering technology involving exosomes as extracellular vesicles enriched with microRNA for the purpose of treating stroke, traumatic brain injury (TBI) including concussion, and neuropathies.
(Binghamton University) New research from Binghamton University, State University at New York finds that mobile coupons can affect both short- and long-term sales goals, and that targeting customers with the right type of mobile coupon can boost revenue.
MeerKAT has drawn astronomers, engineers and data scientists from around the world-- Read more on ScientificAmerican.com
(UCLA Samueli School of Engineering) A team of UCLA engineers and scientists discovered a new and potentially highly effective type of weed killer. This finding could lead to the first new class of commercial herbicides in more than 30 years, an important outcome as weeds continue to develop resistance to current herbicide regimens.
(University of Akron) Researchers will model response of colon cancer cells to anticancer drugs using 3D cultures. By exploring specific mechanisms of a cancer cell's feedback signaling that renders tumors non-responsive, they can design treatment strategies that effectively block tumor growth with significantly reduced toxicity to normal cells.
(University of Washington Health Sciences/UW Medicine) Ultrasonic repositioning of kidney stones will be tested in emergency department patients at UW Medicine as part of the development of a new medical technology for NASA. Astronauts are prone to kidney stones during space missions. The hope is that pushing stones with an ultrasound tractor beam would offer pain relief and avoid medical complications of urinary backups for astronauts affected in space.
(Tokyo Institute of Technology) Researchers at Tokyo Institute of Technology have developed a ruthenium-based perovskite catalyst that shows strong activity even at low temperatures (down to 313 K). The reusable catalyst does not require additives, meaning that it can prevent the formation of toxic by-products. The oxidation of sulfides is a commercially important process with broad applications ranging from chemicals production to environmental management.
(Brown University) Researchers have shown that clusters of boron and lanthanide atoms form interesting 'inverse sandwich' structures that could be useful as molecular magnets.
(Texas A&M University) For decades, Texas A&M University chemist Dr. John A. Gladysz has been mixing metals and carbon to create novel molecules, from the world's longest molecular wires to microscopic gyroscopes controllable by cage size, molecular access and even progress toward unidirectional rotation via external electrical field manipulation.
(The Francis Crick Institute) Scientists have developed a method to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach. The findings could help clinicians decide the best course and delivery of treatment for cancer patients in the future.
(University of Basel) Electrical circuits are constantly being scaled down and extended with specific functions. A new method now allows electrical contact to be established with simple molecules on a conventional silicon chip. The technique promises to bring advances in sensor technology and medicine, as reported in the journal Nature by chemists from the University of Basel and researchers from IBM Research-Zurich in Rüschlikon.